PDE7A2 Antibodies

Santa Cruz Biotechnology features a diverse variety of PDE7A2 monoclonal antibodies for investigating phosphodiesterase 7A2 protein function. The monoclonal antibodies are suitable for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). PDE7A2 is a member of the phosphodiesterase family, which plays a crucial role in regulating intracellular levels of cyclic nucleotides, particularly cAMP. This regulation is vital for numerous cellular processes, including signal transduction, cell proliferation, and apoptosis. Understanding PDE7A2 function is essential for exploring its potential implications in various diseases, including neurodegenerative disorders and cancer. Researchers can utilize PDE7A2 monoclonal antibodies to examine protein expression patterns across different tissues and cell types. Advanced detection methods using secondary antibodies conjugated to horseradish peroxidase (HRP), phycoerythrin (PE), or fluorescein isothiocyanate (FITC) enable precise visualization of PDE7A2 localization and expression. Investigating PDE7A2's role in signal transduction pathways can reveal new insights into disease mechanisms and potential therapeutic targets. Santa Cruz Biotechnology monoclonal antibodies for PDE7A2 support researchers worldwide in advancing scientific understanding of cellular signaling and disease processes.